Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease

Neuroscience Letters

Volumn 276, Issue 2, 1999, Pages 138-139

  Tsai, Shih Jen ^a,b   Liu, Hsiu Chih ^a,b   Liu, Tsung Yun ^a   Wang, Ying Chieh ^a   Hong, Chen Jee ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Association study; Polymorphism; Serotonin receptor 6 gene

Indexed keywords

SEROTONIN 6 RECEPTOR;

AGED; ALLELE; ALZHEIMER DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

EID: 0032699136     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00802-2     Document Type: Article

References (9)

1. Bentley J.C., Sleight A.J., Marsden C.A., Fone K.C.F. Antisense oligonucleotide I.C.V. affects rat performance in the water maze and feeding. J. Psychopharmacol. 11:1997;A64.
2. Bourson A., Borroni E., Austin R.H., Monsma F.J. Jr., Sleight A.J. Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. J. Pharmacol. Exp. Ther. 274:1995;173-180.
3. Gerard C., el Mestikawy S., Lebrand C., Adrien J., Raut M., Traiffort E., Hamon M., Martres M.P. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse. 23:1996;164-173.
4. Gerard C., Martres M.P., Lefevre K., Miquel M.C., Verge D., Lanfumey L., Doucet E., Hamon M., el Mestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 746:1997;207-219.
5. Kohen R., Metcalf M.A., Khan N., Druck T., Huebner K., Lachowicz J.E., Meltzer H.Y., Sibley D.R., Roth B.L., Hamblin M.W. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem. 66:1996;47-56.
6. Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., Kupfer D.J., Reynolds III C.F. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology. 18:1998;407-430.
7. McKhann G., Drachman D., Folstein M., Katqman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: reports of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
8. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43:1993;320-327.
9. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J. Jr., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268:1994;1403-1410.